Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Csaba Péterfia
Observed name:
C. Péterfia
Institution:
University of Pecs
Observed institution:
University of Pecs
ORCID:
0009-0001-6198-7959
Observed ORCID:
0009-0001-6198-7959
OpenAlex ID:
A5115923909
Body composition changes and clinical outcomes in pediatric cystic fibrosis during 24 months of lumacaftor ivacaftor therapy based on real-world data
2025
·
Marcell Imrei
, Adrienn F. Kéri
, et al.
·
Scientific Reports
·
7
PDF
Possible role of pre-vaccination T-lymphocyte subpopulations in the antibody response to COVID-19 vaccines in children undergoing chemotherapy
2026
·
Csaba Péterfia
, Zsolt I. Komlósi
, et al.
·
Frontiers in Immunology
·
2
PDF
Comparison of the Effect of CFTR Modulators elexacaftor/tezacaftor/ivacaftor and lumacaftor/ivacaftor via Serum Human Epididymis Protein 4 Concentration in p.Phe508del-CFTR Homozygous Cystic Fibrosis Patients
2025
·
Marianna Pócsi
, Libor Fila
, et al.
·
Journal of Clinical Medicine
·
1
PDF
P147 Comparison of the effect of CFTR modulator elexacaftor/tezacaftor/ivacaftor and lumacaftor/ivacaftor via human epididymis protein 4 plasma concentration in p.Phe508del-CFTR homozygous CF patients
2025
·
M. Pócsi
, L. Fila
, et al.
·
Journal of Cystic Fibrosis
Pseudo-Bartter syndrome in an infant with cystic fibrosis
2025
·
Anna Csordás
, Dorottya Balogh
, et al.
·
Hungarian Pediatrics
Show more works
View as search
Works count:
5
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type